tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Steven Lichtman, 106 are a BUY (88.33%), 14 are a HOLD (11.67%).
Analyst Steven Lichtman works at OPPENHEIMER with a stock forecast success ratio of 61.25% fulfilled within 162.47 days on average.
Steven Lichtman’s has documented 264 price targets and ratings displayed on 20 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MMSI, Merit Medical Systems at 29-Feb-2024.
Analyst best performing recommendations are on BWAY (BRAINSWAY LTD).
The best stock recommendation documented was for TNDM (TANDEM DIABETES CARE) at 2/27/2019. The price target of $68 was fulfilled within 2 days with a profit of $6.14 (9.93%) receiving and performance score of 49.63.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
82
$9.09 (12.47%)
71
1 days ago
20/21 (95.24%)
$9.09 (12.47%)
319
Buy
72
$-0.91 (-1.25%)
58
21 days ago
9/9 (100%)
$4.25 (6.27%)
98
Buy
77
$4.09 (5.61%)
65
1 months 18 days ago
15/16 (93.75%)
$9.18 (13.54%)
483
Buy
71
$-1.91 (-2.62%)
63
2 months 24 days ago
12/12 (100%)
$6.18 (9.53%)
320
Buy
80
$7.09 (9.72%)
60
2 months 24 days ago
3/4 (75%)
$15.18 (23.42%)
110
Which stock is Steven Lichtman is most bullish on?
Which stock is Steven Lichtman is most reserved on?
What Year was the first public recommendation made by Steven Lichtman?
